Immune-tolerant elastin-like polypeptides (iTEPs) and their application as CTL vaccine carriers

References

• Robinson HL, Amara RR. T cell vaccines for microbial infections. Nat Med 2005;11:s25–32
   PubMed Web of Science ®Google Scholar
• Epstein JE, Tewari K, Lyke KE, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 2011;334:475–80
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Acquavella N, Yu Z, Restifo NP. Therapeutic cancer vaccines: are we there yet? Immunol Rev 2011;239:27–44
   PubMed Web of Science ®Google Scholar
• Schumacher R, Amacker M, Neuhaus D, et al. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro. Vaccine 2005;23:5572–82
   PubMed Web of Science ®Google Scholar
• Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. WIREs Nanomed Nanobiotechnol 2011;3:174–96
   PubMed Web of Science ®Google Scholar
• Goldberg MS. Immunoengineering: how nanotechnology can enhance cancer immunotherapy. Cell 2015;161:201–4
   PubMed Web of Science ®Google Scholar
• Sahdev P, Ochyl L, Moon J. Biomaterials for nanoparticle vaccine delivery systems. Pharm Res 2014;31:2563–82
   PubMed Web of Science ®Google Scholar
• Dreher MR, Simnick AJ, Fischer K, et al. Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. J Am Chem Soc 2008;130:687–94
   PubMed Web of Science ®Google Scholar
• Hassouneh W, Fischer K, MacEwan SR, et al. Unexpected multivalent display of proteins by temperature triggered self-assembly of elastin-like polypeptide block copolymers. Biomacromolecules 2012;13:1598–605
   PubMed Web of Science ®Google Scholar
• Scheller J, Leps M, Conrad U. Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides. Plant Biotechnol J 2006;4:243–9
   PubMed Web of Science ®Google Scholar
• Alexander J, Oseroff C, Dahlberg C, et al. A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery. J Immunol 2002;168:6189–98
   PubMed Web of Science ®Google Scholar
• Livingston BD, Newman M, Crimi C, et al. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 2001;19:4652–60
   PubMed Web of Science ®Google Scholar
• Thomson SA, Khanna R, Gardner J, et al. Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proc Natl Acad Sci USA 1995;92:5845–9
   PubMed Web of Science ®Google Scholar
• Hassouneh W, Christensen T, Chilkoti A. Elastin-like polypeptides as a purification tag for recombinant proteins. Curr Protoc Protein Sci 2010; Chapter 6: Unit 6 11
   Google Scholar
• Da Silva DM, Pastrana DV, Schiller JT, Kast WM. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines. Virology 2001;290:350–60
   PubMed Web of Science ®Google Scholar
• Ruedl C, Schwarz K, Jegerlehner A, et al. Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies. J Virol 2005;79:717–24
   PubMed Web of Science ®Google Scholar
• Liu XS, Xu Y, Hardy L, et al. IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host. J Immunol 2003;171:4765–72
   PubMed Web of Science ®Google Scholar
• Urry DW, Parker TM, Reid MC, Gowda DC. Biocompatibility of the bioelastic materials, poly(GVGVP) and its γ-irradiation cross-linked matrix: summary of generic biological test results. J Bioactive Compatible Polym 1991;6:263–82
   Web of Science ®Google Scholar
• Urry DW, Pattanaik A, Accavitti MA, et al. Transductional elastic and plastic protein-based polymers as potential medical devices. In: Domb AJ, Kost J, Wiseman DM, eds. Handbook of biodegradable polymers. Amsterdam, The Netherlands: CRC Press; 1998
   Google Scholar
• Christiansen M, Matson M, Brazg RL, et al. Weekly subcutaneous doses of Glymera (PB1023) a novel GLP-1 analogue reduce glucose exposure dose-dependently. American Diabetes Association 72nd Scientific Sessions 2012
   Google Scholar
• Cappello J. Genetically engineered protein polymers. In: Domb AJ, Kost J, Wiseman DM, eds. Handbook of biodegradable polymers. Amsterdam: Harwood Academic Publishers; 1997:387–416
   Google Scholar
• Nouri F, Wang X, Chen X, Hatefi A. Reducing the visibility of the vector/DNA nanocomplexes to the immune system by elastin-Like peptides. Pharm Res 2015;32:3018–28
   PubMed Web of Science ®Google Scholar
• Garcia-Arevalo C, Bermejo-Martin JF, Rico L, et al. Immunomodulatory nanoparticles from elastin-like recombinamers: single-molecules for tuberculosis vaccine development. Mol Pharm 2013;10:586–97
   PubMed Web of Science ®Google Scholar
• Moreland LW, McCabe DP, Caldwell JR, et al. Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis. J Rheumatol 2000;27:601–9
   PubMed Web of Science ®Google Scholar
• Rau R, Sander O, van Riel P, et al. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis. J Rheumatol 2003;30:680–90
   PubMed Web of Science ®Google Scholar
• Urry DW. Free energy transduction in polypeptides and proteins based on inverse temperature transitions. Prog Biophys Mol Biol 1992;57:23–57
   PubMed Web of Science ®Google Scholar
• MacEwan SR, Chilkoti A. Elastin-like polypeptides: biomedical applications of tunable biopolymers. Pept Sci 2010;94:60–77
   Web of Science ®Google Scholar
• McDaniel JR, Mackay JA, Quiroz FG, Chilkoti A. Recursive directional ligation by plasmid reconstruction allows rapid and seamless cloning of oligomeric genes. Biomacromolecules 2010;11:944–52
   PubMed Web of Science ®Google Scholar
• Rock KL, Fleischacker C, Gamble S. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant. J Immunol 1993;150:1244–52
   PubMed Web of Science ®Google Scholar
• Zhao P, Dong S, Bhattacharyya J, Chen M. iTEP nanoparticle-delivered salinomycin displays an enhanced toxicity to cancer stem cells in orthotopic breast tumors. Mol Pharm 2014;11:2703–12
   PubMed Web of Science ®Google Scholar
• Lee C, Levin A, Branton D. Copper staining: a five-minute protein stain for sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem 1987;166:308–12
   PubMed Web of Science ®Google Scholar
• Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998;221:35–41
   PubMed Web of Science ®Google Scholar
• Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997;158:2723–30
   PubMed Web of Science ®Google Scholar
• Karttunen J, Sanderson S, Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci 1992;89:6020–4
   PubMed Web of Science ®Google Scholar
• Bernard A, Coitot S, Bremont A, Bernard G. T and B cell cooperation: a dance of life and death. Transplantation 2005;79:S8–11
   Google Scholar
• Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993;11:331–60
   PubMed Web of Science ®Google Scholar
• Murphy K. The humoral immune response in Janeway's immunobiology. London and New York: Garland Science; 2012:387--428
   Google Scholar
• VanRegenmortel MH. Molecular disection of protein antigens. In: VanRegenmortel MH, ed. Structure of antigens. Boca Raton (FL): CRC Press;1992:1–28
   Google Scholar
• Sela M. Antigenicity: some molecular aspects. Science 1969;166:1365–74
   PubMed Web of Science ®Google Scholar
• Murphy K. The development and survival of lymphocytes. in Janeway's Immunobiology. London and New York: Garland Science; 2012:275--333
   Google Scholar
• Liu W, Peng Z, Liu Z, et al. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine 2004;23:366–71
   PubMed Web of Science ®Google Scholar
• Kovacs-Nolan J, Mine Y. Tandem copies of a human rotavirus VP8 epitope can induce specific neutralizing antibodies in BALB/c mice. Biochim Biophys Acta 2006;1760:1884–93
   PubMed Web of Science ®Google Scholar
• Partidos C, Stanley C, Steward M. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. Eur J Immunol 1992;22:2675–80
   PubMed Web of Science ®Google Scholar
• Onda M, Beers R, Xiang L, et al. An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes. Proc Natl Acad Sci USA 2008;105:11311–16
   PubMed Web of Science ®Google Scholar
• Onda M, Nagata S, FitzGerald DJ, et al. Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients. J Immunol 2006;177:8822–34
   PubMed Web of Science ®Google Scholar
• Smejkal GB. The coomassie chronicles: past, present and future perspectives in polyacrylamide gel staining. Expert Rev Proteomics 2004;1:381–7
   PubMed Web of Science ®Google Scholar
• Creighton TE. Proteins: structures and molecular properties. New York: W.H. Freeman Company; 1993
   Google Scholar
• Urry DW, Luan CH, Parker TM, et al. Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity. J Am Chem Soc 1991;113:4346--8
   Web of Science ®Google Scholar
• Meyer DE, Chilkoti A. Quantification of the effects of chain length and concentration on the thermal behavior of elastin-like polypeptides. Biomacromolecules 2004;5:846–1
   PubMed Web of Science ®Google Scholar
• Jefferis R. Aggregation, immune complexes and immunogenicity. MABS 2011;3:503–4
   PubMed Web of Science ®Google Scholar
• Rosenberg AS. Effects of protein aggregates: an immunologic perspective. AAPS J 2006;8:E501–7
   PubMed Web of Science ®Google Scholar
• Zhou L, Hoofring S, Wu Y, et al. Stratification of antibody-positive subjects by antibody level reveals an impact of immunogenicity on pharmacokinetics. AAPS J 2013;15:30–40
   PubMed Web of Science ®Google Scholar
• Kontos S, Hubbell JA. Drug development: longer-lived proteins. Chem Soc Rev 2012;41:2686–95
   PubMed Web of Science ®Google Scholar
• De Groot AS, Scott DW. Immunogenicity of protein therapeutics. Trends Immunol 2007;28:482–90
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration, Guidance for industry immunogenicity assessment for therapeutic protein products. Silver Spring (MD): U.S. Department of Health and Human Services Food and Drug Administration; 2013
   Google Scholar
• Shankar G, Shores E, Wagner C, Mire-Sluis A. Scientific and regulatory considerations on the immunogenicity of biologics. Trends Biotechnol 2006;24:274–80
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Zinkernagel RM. Neutralizing antiviral B cell responses. Annu Rev Immunol 1997;15:235–70
   PubMed Web of Science ®Google Scholar
• Feldmann M, Basten A. The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response. J Exp Med 1971;134:103–19
   PubMed Web of Science ®Google Scholar
• Urry DW. Physical chemistry of biological free energy transductioin as demonstrated by elastic protein-based polymers. J Phys Chem B 1997;101:11007–28
   Web of Science ®Google Scholar
• Chilkoti A, Dreher MR, Meyer DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 2002;54:613–30
   PubMed Web of Science ®Google Scholar
• Liu W, MacKay JA, Dreher MR, et al. Injectable intratumoral depot of thermally responsive polypeptide–radionuclide conjugates delays tumor progression in a mouse model. J Control Release 2010;144:2–9
   PubMed Web of Science ®Google Scholar
• MacKay JA, Chen M, McDaniel JR, et al. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater 2009;8:993–9
   PubMed Web of Science ®Google Scholar
• Shi P, Aluri S, Lin YA, et al. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo. J Control Release 2013;171:330–8
   PubMed Web of Science ®Google Scholar
• Bidwell GL, 3rd, Perkins E, Hughes J, et al. Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. PLoS One 2013;8:e55104
   PubMed Web of Science ®Google Scholar
• Kaspar AA, Reichert JM. Future directions for peptide therapeutics development. Drug Discov Today 2013;18:807–17
   PubMed Web of Science ®Google Scholar
• Le DH, Hanamura R, Pham DH, et al. Self-assembly of elastin-mimetic double hydrophobic polypeptides. Biomacromolecules 2013;14:1028–34
   PubMed Web of Science ®Google Scholar
• Benitez PL, Sweet JA, Fink H, et al. Sequence-specific crosslinking of electrospun, elastin-like protein preserves bioactivity and native-like mechanics. Adv Healthc Mater 2013;2:114–18
   PubMed Web of Science ®Google Scholar